TSC1 and neoplasm: Thus, the differential strength of PKB signaling opposing the activity of FoxO in the context of loss of Tsc1 and PTEN points to the FoxO activation status as the key determinant of the malignant potential of tumors caused by the loss of these tumor suppressors.